Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Matutes

Showing results (41-50 of 316) with videos related to

Pageof 32
Sort By:
Medicina Clinica|March 5, 1983
[Membrane markers in chronic lymphoproliferative diseases]E Matutes, J F San Miguel, D Catovsky
Lancet (London, England)|August 6, 1983
C-type particles in cells from T-cell lymphoma/leukaemia after 5-7 days cultureE Matutes, D Carrington, U Hegde, et al.
British Journal of Haematology|December 1, 1985
Monoclonal antibody OKT17 recognizes most cases of T-cell malignancyE Matutes, A Parreira, R Foa, et al.
Clinical and Experimental Immunology|May 1, 1987
Morphological heterogeneity of Leu7, Leu11 and OKM1 positive lymphocyte subsets: an ultrastructural study with the immunogold methodN Polli, E Matutes, D Robinson, et al.
Leukemia & Lymphoma|August 26, 1998
Case 17: Essential thrombocythaemia with inversion 3 terminating in acute leukaemiaS Killick, E Matutes, J Swansbury, et al.
British Journal of Haematology|August 29, 1998
Absence of HTLV-I/II in T-prolymphocytic leukaemiaR Pawson, T Schulz, E Matutes, et al.
British Journal of Haematology|November 1, 1994
First report of fludarabine in gamma-heavy chain diseaseS Agrawal, Z Abboudi, E Matutes, et al.
Leukemia Research|January 1, 1985
Proliferation in liquid culture of megakaryocytes from the blood of patients with primary myelofibrosis and other myeloproliferative disordersJ A Hibbin, E Matutes, J M Goldman
American Journal of Clinical Pathology|October 1, 1982
Cytochemistry of acid hydrolases in chronic B- and T-cell leukemiasA Crockard, D Chalmers, E Matutes, et al.
British Journal of Haematology|August 1, 1997
The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: a long-term follow-up studyE Matutes, P Meeus, K McLennan, et al.
Pageof 32

Showing results (41-50 of 316) with videos related to

Sort By:
Pageof 32
Medicina Clinica|March 5, 1983
[Membrane markers in chronic lymphoproliferative diseases]E Matutes, J F San Miguel, D Catovsky
Lancet (London, England)|August 6, 1983
C-type particles in cells from T-cell lymphoma/leukaemia after 5-7 days cultureE Matutes, D Carrington, U Hegde, et al.
British Journal of Haematology|December 1, 1985
Monoclonal antibody OKT17 recognizes most cases of T-cell malignancyE Matutes, A Parreira, R Foa, et al.
Clinical and Experimental Immunology|May 1, 1987
Morphological heterogeneity of Leu7, Leu11 and OKM1 positive lymphocyte subsets: an ultrastructural study with the immunogold methodN Polli, E Matutes, D Robinson, et al.
Leukemia & Lymphoma|August 26, 1998
Case 17: Essential thrombocythaemia with inversion 3 terminating in acute leukaemiaS Killick, E Matutes, J Swansbury, et al.
British Journal of Haematology|August 29, 1998
Absence of HTLV-I/II in T-prolymphocytic leukaemiaR Pawson, T Schulz, E Matutes, et al.
British Journal of Haematology|November 1, 1994
First report of fludarabine in gamma-heavy chain diseaseS Agrawal, Z Abboudi, E Matutes, et al.
Leukemia Research|January 1, 1985
Proliferation in liquid culture of megakaryocytes from the blood of patients with primary myelofibrosis and other myeloproliferative disordersJ A Hibbin, E Matutes, J M Goldman
American Journal of Clinical Pathology|October 1, 1982
Cytochemistry of acid hydrolases in chronic B- and T-cell leukemiasA Crockard, D Chalmers, E Matutes, et al.
British Journal of Haematology|August 1, 1997
The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: a long-term follow-up studyE Matutes, P Meeus, K McLennan, et al.
Pageof 32